On May 2, 2023, Nicole Steinmetz, Ph.D., advised the board of directors of Mosaic ImmunoEngineering, Inc. of her intention to resign as a member of the board of directors and acting Chief Scientific Officer effective immediately. Dr. Steinmetz confirmed to the Company's board of directors that her resignation is not due to a disagreement with the Company on any matter relating to the Company's operations, policies or practices. Dr. Steinmetz will remain engaged with the Company as a scientific advisor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3791 USD | -2.78% | -36.82% | -36.82% |
1st Jan change | Capi. | |
---|---|---|
-36.82% | 2.75M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CPMV Stock
- News Mosaic ImmunoEngineering, Inc.
- Mosaic Immunoengineering, Inc. Announces Nicole Steinmetz, Ph.D., to Resign as A Member of the Board of Directors and Acting Chief Scientific Officer